Literature DB >> 6304995

Frequency and antigenicity of type C retrovirus-like particles in human placentas.

H Ueno, M Imamura, K Kikuchi.   

Abstract

Seventeen placentas from normal Japanese women, obtained from 15 full term gestations and at 2 earlier gestational periods, were observed by electron microscopy for the presence of type C retrovirus-like particles. Immature free and budding particles were found in 16 placentas including those obtained pre-term. Free virus-like particles were seen in the intercellular spaces and within the lysosomes of syncytiotrophoblasts of the chorionic villi. Forms budding from syncytiotrophoblasts were found in 3 cases. Coincident data with the electron microscopic observations were obtained by immunohistological methods. Specific positive staining with antisera against heterogeneic whole murine leukaemia virus were seen within the cytoplasm of trophoblastic cells both in and along the basal lamina.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304995     DOI: 10.1007/bf00627006

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  20 in total

1.  Cell-mediated immune response to simian oncornavirus antigens in pregnant women.

Authors:  L Thiry; S Sprecher-Goldberger; M Bossens; F Neuray
Journal:  J Natl Cancer Inst       Date:  1978-03       Impact factor: 13.506

2.  Virus-like particles in placentas from normal individuals and patients with systemic lupus erythematosus.

Authors:  E R Dirksen; J A Levy
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

3.  Brief communication: C-type particles in normal human placentas.

Authors:  S S Kalter; R J Helmke; R L Heberling; M Panigel; A K Fowler; J E Strickland; A Hellman
Journal:  J Natl Cancer Inst       Date:  1973-04       Impact factor: 13.506

4.  Characterization of the reverse transcriptase from a new retrovirus (HTLV) produced by a human cutaneous T-cell lymphoma cell line.

Authors:  H M Rho; B Poiesz; F W Ruscetti; R C Gallo
Journal:  Virology       Date:  1981-07-15       Impact factor: 3.616

5.  Antibodies in human sera reactive against an internal structural protein of human T-cell lymphoma virus.

Authors:  V S Kalyanaraman; M G Sarngadharan; P A Bunn; J D Minna; R C Gallo
Journal:  Nature       Date:  1981-11-19       Impact factor: 49.962

6.  Antigen related to mammalian type-C RNA viral p30 proteins is located in renal glomeruli in human systemic lupus erythematosus.

Authors:  R C Mellors; J W Mellors
Journal:  Proc Natl Acad Sci U S A       Date:  1976-01       Impact factor: 11.205

7.  Activation of leukemia viruses by graft-versus-host and mixed lymphocyte reactions in vitro.

Authors:  M S Hirsch; S M Phillips; C Solnik; P H Black; R S Schwartz; C B Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1972-05       Impact factor: 11.205

8.  Characterization and distribution of nucleic acid sequences of a novel type C retrovirus isolated from neoplastic human T lymphocytes.

Authors:  M S Reitz; B J Poiesz; F W Ruscetti; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

9.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

10.  Detection of the human T cell lymphoma virus p19 in cells of some patients with cutaneous T cell lymphoma and leukemia using a monoclonal antibody.

Authors:  M Robert-Guroff; F W Ruscetti; L E Posner; B J Poiesz; R C Gallo
Journal:  J Exp Med       Date:  1981-12-01       Impact factor: 14.307

View more
  2 in total

Review 1.  On viruses, sex, and motherhood.

Authors:  L P Villarreal; L P Villareal
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

2.  T-Ag inhibits implantation by EC cell derived embryoid bodies.

Authors:  A Espinosa; L P Villarreal
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.